Cargando…
The Bloom Is in Bud for Interstitial Lung Diseases
Autores principales: | Noth, Imre, Otoupalova, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667894/ https://www.ncbi.nlm.nih.gov/pubmed/32795242 http://dx.doi.org/10.1164/rccm.202007-2855ED |
Ejemplares similares
-
Association of antinuclear antibody seropositivity with inhaled environmental exposures in patients with interstitial lung disease
por: Biblowitz, Kathleen, et al.
Publicado: (2021) -
Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases
por: Cottin, Vincent
Publicado: (2019) -
Automated CT Analysis of Major Forms of Interstitial Lung Disease
por: Crews, Marlee S., et al.
Publicado: (2020) -
Risk Stratifying Interstitial Lung Abnormalities to Guide Early Diagnosis of Interstitial Lung Diseases
por: Wijsenbeek, Marlies S., et al.
Publicado: (2022) -
Idiopathic Pulmonary Fibrosis Genetic Risk Factors, Function, and Mechanisms? The Concepts Are Starting to Gel
por: Bonham, Catherine A., et al.
Publicado: (2022)